Navigation Links
Cynosure Introduces Higher Power Smartlipo(TM) LaserBodySculpting Workstation

WESTFORD, Mass., Cynosure, Inc., a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced the launch of a new, higher power Smartlipo LaserBodySculpting (SM) Workstation. The new 10-watt workstation is intended for high-volume aesthetic laser practices, allowing a physician to complete a typical laser-assisted liposuction procedure in about half the time as the original 6-watt workstation.

"Cynosure's new 10-watt Smartlipo workstation allows me to treat patients quickly and efficiently, with the same level of safety and efficacy as the 6- watt system," said Bruce Katz, M.D., founder of New York's Juva Skin & Laser Center. "For example, an area of localized fat under the chin can be treated in about eight minutes with the 10-watt Smartlipo system, compared with about 15 minutes with the 6-watt workstation."

Introduced by Cynosure in January, the minimally invasive Smartlipo workstation is an innovative system designed as an alternative to traditional liposuction in patients with smaller areas of localized fat. The system's proprietary pulsing format delivers laser energy that liquefies localized deposits of fat that is then removed through a cannula.

In addition the laser energy coagulates the tissue, thereby sculpting body contours and tightening the skin. The procedure generally causes less bleeding, swelling and bruising than traditional liposuction, resulting in fewer complications and faster recovery. Cynosure received U.S. Food and Drug Administration clearance to market Smartlipo in the fourth quarter of 2006.

According to cosmetic surgeon Robert Gotkin, M.D., co-director of Cosmetique in New York, "The introduction of its new, higher power Smartlipo reflects Cynosure's commitment to advance its customers' practices with innovative products designed for patient efficiency."

"We believe the introduction of the 10-watt platform will acc elerate the adoption of Smartlipo in the marketplace," said Cynosure President and Chief Executive Officer Michael Davin. "We have been very pleased with the response to Smartlipo. Due to the short and minimally invasive nature of the Smartlipo treatment, patients who may have never considered traditional liposuction are having Smartlipo procedures performed."

"We believe that expanding our family of products with a more powerful version of the Smartlipo workstation will enhance our competitive position," Davin said. "The faster treatment times afforded by this 10-watt platform will be attractive to medical professionals, particularly those with high- volume practices."

The 10-watt Smartlipo workstation is available as a standalone unit or as an upgrade to the 6-watt system. Cynosure previously announced that it has added a 10-person specialty surgical sales force to market its Smartlipo family of workstations in North America.

About Cynosure, Inc.

Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions, laser lipolysis and temporarily reduce the appearance of cellulite.

Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991.


'"/>




Related medicine news :

1. TI Cycles Introduces Foldman
2. Canada Introduces Mandatory Nutrition Labeling
3. Cuba Introduces New Device for Detecting Vascular Diseases
4. China Introduces Solar-powered Baths
5. Allergan Introduces ‘Dermal Filler’ for Smile Lins
6. UAE Introduces Cervical Cancer Vaccine
7. Iceland Introduces Smoking Ban in Bars and Restaurants
8. Higher Risk of Asthma in children with autoimmune disease
9. Death Risk Higher in Obese Women with Colon Cancer
10. Women With Diabetes Have a Higher Risk of Depression
11. Individuals Born In May At A Higher Risk Of Developing Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... ... Haute Living, is proud to recognize Dr. Barry M. Weintraub as a prominent ... “the most beautiful women in the world, and the most handsome men, look ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
Breaking Medicine Technology: